ET
LGND icon

Equitable Trust’s Ligand Pharmaceuticals LGND Stock Holding History

Equitable Trust’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
5,640
+605
+12% +$143K 0.07% 179
2026
Q1 		$1.01M Hold
5,035
– – 0.05% 230
2025
Q4 		$952K Sell
5,035
-880
-15% -$169K 0.04% 242
2025
Q3 		$1.05M Sell
5,915
-330
-5% -$49.1K 0.05% 226
2025
Q2 		$710K Buy
6,245
+1,710
+38% +$183K 0.04% 272
2025
Q1 		$477K Buy
4,535
+755
+20% +$85.4K 0.03% 313
2024
Q4 		$405K Sell
3,780
-300
-7% -$33.9K 0.02% 360
2024
Q3 		$408K Hold
4,080
– – 0.03% 346
2024
Q2 		$344K Buy
+4,080
New +$325K 0.02% 358

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Equitable Trust's LGND Position: Q2 2026 in Review

Equitable Trust increased its Ligand Pharmaceuticals (LGND) stake by 12% in Q2 2026, buying an estimated $143K and bringing the position to 5,640 shares worth $1.78M. The position accounts for 0.07% of the portfolio, ranked #179.

Equitable Trust first reported a position in LGND in Q2 2024 and has held it in 9 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Equitable Trust held 5,640 shares of Ligand Pharmaceuticals worth $1.78M as of Q2 2026.
  • Equitable Trust bought 605 Ligand Pharmaceuticals shares in Q2 2026, an estimated $143K.
  • Ligand Pharmaceuticals made up 0.07% of Equitable Trust's portfolio in Q2 2026, its #179 holding.
  • Equitable Trust first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.